Literature DB >> 2039465

Characterization of release of basic fibroblast growth factor from bovine retinal endothelial cells in monolayer cultures.

R A Brooks1, J M Burrin, E M Kohner.   

Abstract

Release of basic fibroblast growth factor (bFGF) was investigated in bovine retinal endothelial cells (BREC) maintained in monolayer culture. Confluent cells released bFGF into serum-free culture medium or medium containing 5% serum at rates of up to 105.2 and 61.3 pM/day respectively. bFGF release coincided with a decrease in monolayer cell number and increases in lactate dehydrogenase (LDH) concentration and cells and cell-debris particles in the medium, which suggested that cell damage and lysis were responsible for growth-factor release. Maximum bFGF release at 24 h (230 +/- 10 pM) occurred when the cells were treated with lipopolysaccharide (10 micrograms/ml), which also produced the greatest changes in parameters of cell damage. Sub-confluent cells showed little overt damage at 24 h, but released bFGF (78 +/- 20 pM) along with LDH, indicating that some cell lysis had occurred. Insulin-like growth factor 1 (IGF-1) was also released into serum-free culture medium at a rate of 0.34 nM/day, but not into medium containing serum or when the cells were treated with lipopolysaccharide. This implies that the mechanism of IGF-1 release is different from that of bFGF and is not related to cell damage. Culture medium conditioned by BREC stimulated the proliferation of these cells, as measured by an increase in their incorporation of [methyl-3H]thymidine from 7550 +/- 479 to 10467 +/- 924 d.p.m. These results demonstrate that bFGF is released from damaged BREC and that medium conditioned by these cells can stimulate retinal-endothelial-cell proliferation. This strengthens the case for an involvement of this growth factor in retinal neovascularization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039465      PMCID: PMC1151151          DOI: 10.1042/bj2760113

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Purification of a fibroblast growth factor from bovine pituitary.

Authors:  D Gospodarowicz
Journal:  J Biol Chem       Date:  1975-04-10       Impact factor: 5.157

2.  Dual control of cell growth by somatomedins and platelet-derived growth factor.

Authors:  C D Stiles; G T Capone; C D Scher; H N Antoniades; J J Van Wyk; W J Pledger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

3.  Isolation and characterization of acidic and basic fibroblast growth factor.

Authors:  D Gospodarowicz
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Variables controlling somatomedin production by cultured human fibroblasts.

Authors:  D R Clemmons; D S Shaw
Journal:  J Cell Physiol       Date:  1983-05       Impact factor: 6.384

5.  Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor.

Authors:  D Gospodarowicz; J Cheng; G M Lui; A Baird; P Böhlent
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.

Authors:  A Sivalingam; J Kenney; G C Brown; W E Benson; L Donoso
Journal:  Arch Ophthalmol       Date:  1990-06

7.  Stabilization of fibroblast growth factors by a non-cytotoxic zwitterionic detergent, 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS).

Authors:  Y Matuo; N Nishi; Y Muguruma; Y Yoshitake; Y Masuda; K Nishikawa; F Wada
Journal:  In Vitro Cell Dev Biol       Date:  1988-05

8.  Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor.

Authors:  Y Shing; J Folkman; R Sullivan; C Butterfield; J Murray; M Klagsbrun
Journal:  Science       Date:  1984-03-23       Impact factor: 47.728

9.  Retinal capillary endothelial cells prefer different substrates for growth and migration.

Authors:  L C McIntosh; L Muckersie; J V Forrester
Journal:  Tissue Cell       Date:  1988       Impact factor: 2.466

10.  Human diabetic serum does not stimulate bovine retinal endothelial cell growth in culture.

Authors:  D Kinshuck; R A Brooks; E M Kohner
Journal:  Curr Eye Res       Date:  1989-07       Impact factor: 2.424

View more
  7 in total

Review 1.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

2.  Amyloid beta toxicity dependent upon endothelial cell state.

Authors:  Mercedes Balcells; Joseph S Wallins; Elazer R Edelman
Journal:  Neurosci Lett       Date:  2008-06-27       Impact factor: 3.046

3.  A study of the effects of human blood derivatives and individual growth factors on [3H]thymidine uptake in bovine retinal pericytes and endothelial cells.

Authors:  A A Dosso; R A Brooks; E Beltramo; P A Molinatti; S M Kanse; E M Kohner; M Porta
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

4.  Conditioned media of carcinoma cells cultured in hypoxic microenvironment stimulate angiogenesis in vitro; relationship to basic fibroblast growth factor.

Authors:  H Ishibashi; K Nakagawa; Y Nakashima; K Sueishi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Basic fibroblast growth factor regulates type I collagen and collagenase gene expression in human smooth muscle cells.

Authors:  S H Kennedy; H Qin; L Lin; E M Tan
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

6.  Production of IGF-I and IGF binding proteins by retinal cells in vitro.

Authors:  P Moriarty; M Boulton; A Dickson; D McLeod
Journal:  Br J Ophthalmol       Date:  1994-08       Impact factor: 4.638

7.  Protein release through nonlethal oncotic pores as an alternative nonclassical secretory pathway.

Authors:  William J Chirico
Journal:  BMC Cell Biol       Date:  2011-10-18       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.